Key terms
About AXDX
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AXDX news
Apr 01
8:40am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA), DarioHealth (DRIO) and Accelerate Diagnostics (AXDX)
Apr 01
8:38am ET
Accelerate Diagnostics price target lowered to $1 from $2 at Craig-Hallum
Mar 30
2:01am ET
Stockholders Beware: Accelerate Diagnostics’ Surge in Authorized Shares Signals Potential Dilution Risk
Mar 28
4:23pm ET
Accelerate Diagnostics reports Q4 EPS (89c), consensus (75c)
Jan 08
9:02am ET
Accelerate Diagnostics price target lowered to $2 from $5 at Craig-Hallum
Jan 08
9:01am ET
Analysts Conflicted on These Healthcare Names: Schrodinger (SDGR), Accelerate Diagnostics (AXDX) and Staar Surgical (STAA)
Jan 07
8:08pm ET
Accelerate Diagnostics reports preliminary FY23 revenue$12.1M, consensus $12.81M
No recent press releases are available for AXDX
AXDX Financials
Key terms
Ad Feedback
AXDX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AXDX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
